BDPT 0.01 BioAdaptives, Inc.
Range: | 3.0E-4-0.0026 | Vol Avg: | 7846103 | Last Div: | 0 | Changes: | 0 |
Beta: | 0.25 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
Sector: | Consumer Defensive | IPO: | Wed Jul 09 2014 | Empoloyees: | 3 |
CUSIP: | 09072U107 | CIK: | 0001575142 | ISIN: | US09072U1079 | Country: | US |
CEO: | Mr. James Keener | Website: | https://www.shopbioadaptives.com |
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.